According to Antares Pharma's latest financial reports the company's current revenue (TTM) is $0.18 B. In 2021 the company made a revenue of $0.18 B an increase over the years 2020 revenue that were of $0.14 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2021 | $0.18 B | 22.98% |
2020 | $0.14 B | 20.78% |
2019 | $0.12 B | 94.9% |
2018 | $63.55 M | 16.58% |
2017 | $54.51 M | 4.39% |
2016 | $52.22 M | 14.38% |
2015 | $45.65 M | 72.28% |
2014 | $26.5 M | 28.53% |
2013 | $20.61 M | -8.67% |
2012 | $22.57 M | 37.17% |
2011 | $16.45 M | 28.39% |
2010 | $12.81 M | 54.24% |
2009 | $8.31 M | 46.82% |
2008 | $5.66 M | -27.95% |
2007 | $7.85 M | 84.07% |
2006 | $4.26 M | 91.86% |
2005 | $2.22 M | -18.98% |
2004 | $2.74 M | -27.49% |
2003 | $3.78 M | -5.23% |
2002 | $3.99 M | 14.21% |
2001 | $3.49 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 50,460.38% | ๐บ๐ธ USA |
Pfizer PFE | $58.49 B | 31,694.96% | ๐บ๐ธ USA |
Eli Lilly LLY | $34.12 B | 18,447.52% | ๐บ๐ธ USA |
Becton Dickinson BDX | $19.49 B | 10,494.51% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | $0.48 B | 164.60% | ๐บ๐ธ USA |
Retractable Technologies RVP | $43.59 M | -76.30% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.84 B | 8,512.80% | ๐ฎ๐ฑ Israel |
West Pharmaceutical WST | $2.94 B | 1,503.31% | ๐บ๐ธ USA |